{"id":"https://openalex.org/W2338833767","doi":null,"title":"Common adverse effects of antiretroviral therapy for HIV disease.","display_name":"Common adverse effects of antiretroviral therapy for HIV disease.","publication_year":2011,"publication_date":"2011-06-15","ids":{"openalex":"https://openalex.org/W2338833767","mag":"2338833767","pmid":"https://pubmed.ncbi.nlm.nih.gov/21671545"},"language":"en","primary_location":{"id":"pmid:21671545","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21671545","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American family physician","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070919727","display_name":"Carin Reust","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I76835614","display_name":"University of Missouri","ror":"https://ror.org/02ymw8z06","country_code":"US","type":"education","lineage":["https://openalex.org/I76835614"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Carin E Reust","raw_affiliation_strings":["University of Missouri School of Medicine, Columbia, 65212, USA. reustc@health.missouri.edu","University of Missouri School of Medicine, Columbia 65212, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Missouri School of Medicine, Columbia, 65212, USA. reustc@health.missouri.edu","institution_ids":["https://openalex.org/I76835614"]},{"raw_affiliation_string":"University of Missouri School of Medicine, Columbia 65212, USA","institution_ids":["https://openalex.org/I76835614"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5070919727"],"corresponding_institution_ids":["https://openalex.org/I76835614"],"apc_list":null,"apc_paid":null,"fwci":3.3086,"has_fulltext":false,"cited_by_count":104,"citation_normalized_percentile":{"value":0.92023749,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"83","issue":"12","first_page":"1443","last_page":"51"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8125,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8125,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.1858000010251999,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8830000162124634},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.722000002861023},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9570000171661377},{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":0.8849999904632568},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.968999981880188},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":1.0},{"id":"https://openalex.org/keywords/maraviroc","display_name":"maraviroc","score":0.8059999942779541},{"id":"https://openalex.org/keywords/raltegravir","display_name":"raltegravir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8420000076293945},{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.8859999775886536},{"id":"https://openalex.org/keywords/lactic-acidosis","display_name":"lactic acidosis","score":0.949999988079071},{"id":"https://openalex.org/keywords/lipodystrophy","display_name":"lipodystrophy","score":0.9909999966621399},{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.9169999957084656},{"id":"https://openalex.org/keywords/neuropsychiatric-symptoms","display_name":"neuropsychiatric symptoms","score":0.746999979019165},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.6570000052452087},{"id":"https://openalex.org/keywords/rhabdomyolysis","display_name":"rhabdomyolysis","score":0.8130000233650208},{"id":"https://openalex.org/keywords/bone-disorders","display_name":"bone disease","score":0.5419999957084656},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.7990000247955322},{"id":"https://openalex.org/keywords/lipid-management","display_name":"lipid control","score":0.6240000128746033},{"id":"https://openalex.org/keywords/adverse-effects-monitoring","display_name":"adverse effects monitoring","score":0.5410000085830688}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9040498733520508},{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.6970604062080383},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6474645733833313},{"id":"https://openalex.org/C2780941825","wikidata":"https://www.wikidata.org/wiki/Q1538213","display_name":"Lipodystrophy","level":5,"score":0.5348272323608398},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4989168643951416},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.45960333943367004},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3766986131668091},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33844470977783203},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.26580655574798584},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24605074524879456},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.08267024159431458},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019317","descriptor_name":"Evidence-Based Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:21671545","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21671545","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American family physician","raw_type":"Journal Article"},{"id":"mag:2338833767","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21671545","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W178407414","https://openalex.org/W1767400858","https://openalex.org/W1968442008","https://openalex.org/W1983837630","https://openalex.org/W1985722970","https://openalex.org/W1990746088","https://openalex.org/W1996085799","https://openalex.org/W1996747410","https://openalex.org/W2003293061","https://openalex.org/W2006498349","https://openalex.org/W2025740330","https://openalex.org/W2061555322","https://openalex.org/W2072493464","https://openalex.org/W2077788073","https://openalex.org/W2081303365","https://openalex.org/W2081686997","https://openalex.org/W2084385720","https://openalex.org/W2085858114","https://openalex.org/W2125243069","https://openalex.org/W2126861692","https://openalex.org/W2128513451","https://openalex.org/W2130255770","https://openalex.org/W2143265231","https://openalex.org/W2148750104","https://openalex.org/W2150504993","https://openalex.org/W2159686293","https://openalex.org/W2160230582","https://openalex.org/W2161993838","https://openalex.org/W2167865974","https://openalex.org/W2168784348","https://openalex.org/W2171236519","https://openalex.org/W2180106912","https://openalex.org/W2183940924","https://openalex.org/W2273946964","https://openalex.org/W2303359354","https://openalex.org/W2594780159"],"related_works":["https://openalex.org/W2296037621","https://openalex.org/W1984632572","https://openalex.org/W2067177219","https://openalex.org/W3166449914","https://openalex.org/W2148083950","https://openalex.org/W2310958365","https://openalex.org/W2324401629","https://openalex.org/W7048847134","https://openalex.org/W7220692339","https://openalex.org/W2019425059"],"abstract_inverted_index":{"Family":[0],"physicians":[1],"are":[2,20,47,59,73,113,148],"treating":[3],"patients":[4,205],"infected":[5],"with":[6,49,61,75,103,118,120],"human":[7],"immunodeficiency":[8],"virus":[9,28],"in":[10,204,240],"their":[11],"practices":[12],"more":[13],"often.":[14],"Long-term":[15,210],"complications":[16],"of":[17,34,111,123,126,136,168],"this":[18],"disease":[19],"multifactorial":[21],"and":[22,53,67,70,78,80,87,97,106,128,145,156,176,188,220,223,225],"can":[23,236],"be":[24,193,202,237],"related":[25,212],"to":[26,31,115,182,213],"the":[27,88,121,152,241],"itself":[29],"or":[30],"adverse":[32,166],"effects":[33,110,167],"antiretroviral":[35,169,214],"therapy.":[36],"Each":[37],"drug":[38,132],"class":[39],"has":[40],"side":[41],"effects:":[42],"nucleoside/nucleotide":[43],"reverse":[44,56,142],"transcriptase":[45,57,143],"inhibitors":[46,58,72,144,147],"associated":[48,60,74,102],"lactic":[50],"acidosis,":[51],"lipodystrophy,":[52],"hyperlipidemia;":[54],"non-nucleoside":[55],"neuropsychiatric":[62],"symptoms,":[63],"rash,":[64],"liver":[65],"toxicity,":[66],"lipid":[68,81,186,221,232],"abnormalities;":[69],"protease":[71,146],"gastrointestinal":[76],"intolerance":[77],"glucose":[79],"abnormalities.":[82],"The":[83],"entry":[84],"inhibitor":[85,90],"maraviroc":[86],"integrase":[89],"raltegravir":[91,112],"have":[92,160],"been":[93],"approved":[94],"for":[95,134,165,190,231],"treatment-naive":[96],"treatment-experienced":[98],"patients.":[99],"Maraviroc":[100],"is":[101,139],"bronchitis,":[104],"nasopharyngitis,":[105],"esophageal":[107],"candidiasis.":[108],"Adverse":[109],"comparable":[114],"those":[116],"experienced":[117],"placebo,":[119],"exception":[122],"increased":[124],"risk":[125],"myopathy":[127],"rhabdomyolysis.":[129],"Information":[130],"about":[131],"interactions":[133],"both":[135],"these":[137,234],"medications":[138],"limited.":[140],"Non-nucleoside":[141],"primarily":[149],"metabolized":[150],"through":[151],"cytochrome":[153],"P450":[154],"system,":[155],"as":[157,239],"a":[158,172],"result":[159],"numerous":[161],"drug-drug":[162],"interactions.":[163],"Monitoring":[164],"therapy":[170,215],"includes":[171,216],"complete":[173],"blood":[174],"count":[175],"comprehensive":[177],"metabolic":[178],"profile":[179,187],"every":[180],"three":[181],"six":[183],"months.":[184],"A":[185],"urinalysis":[189],"proteinuria":[191],"should":[192,201],"per-":[194],"formed":[195],"annually.":[196],"Dual":[197],"energy":[198],"x-ray":[199],"absorptiometry":[200],"considered":[203],"older":[206],"than":[207],"50":[208],"years.":[209],"morbidity":[211],"liver,":[217],"renal,":[218],"glucose,":[219],"abnormalities,":[222],"cardiovascular":[224],"bone":[226],"disease.":[227],"With":[228],"some":[229],"exceptions":[230],"management,":[233],"morbidities":[235],"managed":[238],"general":[242],"population.":[243]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}